Investing
Siemens Healthineers Q1 sales beat expectations on strong Varian unit
© Reuters. Siemens Healthineers logo is seen on an item of clothing in manufacturing plant in Forchheim near Nuremberg, Germany, October 7, 2016. REUTERS/Michaela Rehle
BERLIN (Reuters) – German medical equipment maker Siemens Healthineers on Thursday posted first-quarter revenue above expectations and an operating result in line with consensus, driven by its U.S. cancer treatment unit Varian.
It said Varian’s revenue improved most in China after sales had been affected by supply chain delays in the prior-year period.
Adjusted earnings before interest and taxes (EBIT) reached 742 million euros ($802 million) in the three months through December on revenue of 5.18 billion, the group said.
Analysts had expected quarterly adjusted EBIT of 742 million euros on revenue of 5.11 billion, according to a company-provided poll.
The company’s diagnostics unit, which encompasses its laboratory testing and includes the now-ended COVID-19-test business, saw its quarterly revenue fall 7.7% in the first quarter.
Siemens Healthineers confirmed its 2024 guidance and still expects adjusted basic earnings per share to be between 2.10 and 2.30 euros and comparable revenue growth of between 4.5% to 6.5%.
($1 = 0.9257 euros)
Read the full article here
-
Side Hustles6 days ago
3 Steps You Can’t Miss When Growing Your Business
-
Make Money7 days ago
15 Jobs That Will Shrink the Fastest Over the Next Decade
-
Side Hustles7 days ago
How to Maximize Your Profits With This Annual 8-Step Checklist
-
Investing7 days ago
Netherlands stocks lower at close of trade; AEX down 0.80% By Investing.com
-
Passive Income7 days ago
Why Email Marketing Is Still Your Business’s Most Powerful Tool
-
Side Hustles7 days ago
Want to Start a Business? Consider Buying One Instead — Here’s Why.
-
Investing6 days ago
Germany stocks lower at close of trade; DAX down 0.65% By Investing.com
-
Investing6 days ago
How I Transformed My Business by Letting Go of Low-Value Tasks